385 related articles for article (PubMed ID: 16759765)
1. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
Moore QC; Bosarge JR; Quin LR; McDaniel LS
Vaccine; 2006 Jul; 24(29-30):5755-61. PubMed ID: 16759765
[TBL] [Abstract][Full Text] [Related]
2. The genetic background of Streptococcus pneumoniae affects protection in mice immunized with PspA.
He X; McDaniel LS
FEMS Microbiol Lett; 2007 Apr; 269(2):189-95. PubMed ID: 17355599
[TBL] [Abstract][Full Text] [Related]
3. PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.
Xin W; Li Y; Mo H; Roland KL; Curtiss R
Infect Immun; 2009 Oct; 77(10):4518-28. PubMed ID: 19687204
[TBL] [Abstract][Full Text] [Related]
4. Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production.
Ferreira DM; Darrieux M; Oliveira ML; Leite LC; Miyaji EN
Clin Vaccine Immunol; 2008 Mar; 15(3):499-505. PubMed ID: 18184825
[TBL] [Abstract][Full Text] [Related]
5. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
6. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
Hanniffy SB; Carter AT; Hitchin E; Wells JM
J Infect Dis; 2007 Jan; 195(2):185-93. PubMed ID: 17191163
[TBL] [Abstract][Full Text] [Related]
7. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
8. Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae.
Bosarge JR; Watt JM; McDaniel DO; Swiatlo E; McDaniel LS
Infect Immun; 2001 Sep; 69(9):5456-63. PubMed ID: 11500417
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae.
Coats MT; Benjamin WH; Hollingshead SK; Briles DE
Vaccine; 2005 Jul; 23(33):4257-62. PubMed ID: 16005736
[TBL] [Abstract][Full Text] [Related]
10. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.
Briles DE; Hollingshead SK; King J; Swift A; Braun PA; Park MK; Ferguson LM; Nahm MH; Nabors GS
J Infect Dis; 2000 Dec; 182(6):1694-701. PubMed ID: 11069242
[TBL] [Abstract][Full Text] [Related]
11. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
Cao J; Chen D; Xu W; Chen T; Xu S; Luo J; Zhao Q; Liu B; Wang D; Zhang X; Shan Y; Yin Y
Vaccine; 2007 Jun; 25(27):4996-5005. PubMed ID: 17524530
[TBL] [Abstract][Full Text] [Related]
12. Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A).
Ferreira DM; Oliveira ML; Moreno AT; Ho PL; Briles DE; Miyaji EN
Microb Pathog; 2010 Jun; 48(6):205-13. PubMed ID: 20206678
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae.
Vadesilho CF; Ferreira DM; Moreno AT; Chavez-Olortegui C; Machado de Avila RA; Oliveira ML; Ho PL; Miyaji EN
Microb Pathog; 2012; 53(5-6):243-9. PubMed ID: 22981893
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of PspA (pneumococcal surface protein A)-based DNA vaccines: contribution of both humoral and cellular immune responses.
Miyaji EN; Dias WO; Tanizaki MM; Leite LC
FEMS Immunol Med Microbiol; 2003 Jun; 37(1):53-7. PubMed ID: 12770760
[TBL] [Abstract][Full Text] [Related]
15. DNA vaccines based on genetically detoxified derivatives of pneumolysin fail to protect mice against challenge with Streptococcus pneumoniae.
Ferreira DM; Arêas AP; Darrieux M; Leite LC; Miyaji EN
FEMS Immunol Med Microbiol; 2006 Mar; 46(2):291-7. PubMed ID: 16487311
[TBL] [Abstract][Full Text] [Related]
16. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
[TBL] [Abstract][Full Text] [Related]
17. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260.
McDaniel LS; Ralph BA; McDaniel DO; Briles DE
Microb Pathog; 1994 Nov; 17(5):323-37. PubMed ID: 7723659
[TBL] [Abstract][Full Text] [Related]
18. Immunization with PspA incorporated into a poly(ethylene oxide) matrix elicits protective immunity against Streptococcus pneumoniae.
Moore QC; Johnson L; Repka M; McDaniel LS
Clin Vaccine Immunol; 2007 Jun; 14(6):789-91. PubMed ID: 17460113
[TBL] [Abstract][Full Text] [Related]
19. Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades.
Miyaji EN; Ferreira DM; Lopes AP; Brandileone MC; Dias WO; Leite LC
Infect Immun; 2002 Sep; 70(9):5086-90. PubMed ID: 12183557
[TBL] [Abstract][Full Text] [Related]
20. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.
Villena J; Medina M; Racedo S; Alvarez S
J Microbiol Immunol Infect; 2010 Feb; 43(1):1-10. PubMed ID: 20434117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
